newsfilter
← Latest News
GlobeNewswire·

Aequus Extends Commercial Agreement for Specialty Product Tacrolimus IR in Canada

VANCOUVER, British Columbia, Jan. 24, 2022 (GLOBE NEWSWIRE) -- Aequus Pharmaceuticals Inc. (TSXV:AQS, OTCQB:AQSZF) ("Aequus" or the "Company"), announced today that it has agreed to an extension of terms for its promotional service agreement with Sando